Moleculin Biotech Inc — Cash Flow (NASDAQ:MBRX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 17.8 M19 M27.6 M24.1 M23.86 M 22.45 M Cash from investing activities 374 K19 K67 K124 K13 K 0 Cash from financing activities 22.55 M74.72 M23 K4.65 M4.63 M 19.8 M Free cash flow 17.42 M18.98 M27.53 M23.98 M23.85 M 22.45 M

News

Moleculin Biotech releases CEO update on leukemia trial

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.54%

Moleculin Biotech stock plunges after warrant exercise agreement

Moleculin Biotech raises $8.3 million through warrant exercise

Moleculin Biotech stock rises as AML drug trial shows promising results

Moleculin reports promising early data in pivotal AML treatment trial

Moleculin Biotech stock rises after securing key Japanese patent

Moleculin receives patent allowance in Japan for Annamycin preparation method

Moleculin launches CEO Corner to enhance investor communication

Moleculin Biotech stockholders approve warrant issuance, reject name change

Moleculin’s Annamycin shows no cardiotoxicity in cancer trials

Moleculin expects first MIRACLE trial data readout in Q1 2026